These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10467400

  • 1. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA.
    Wang W, Abbruzzese JL, Evans DB, Chiao PJ.
    Oncogene; 1999 Aug 12; 18(32):4554-63. PubMed ID: 10467400
    [Abstract] [Full Text] [Related]

  • 2. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ.
    Clin Cancer Res; 1999 Jan 12; 5(1):119-27. PubMed ID: 9918209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.
    Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M.
    Clin Cancer Res; 2001 Dec 12; 7(12):4136-42. PubMed ID: 11751513
    [Abstract] [Full Text] [Related]

  • 6. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 7. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.
    Oncogene; 2002 Sep 19; 21(42):6510-9. PubMed ID: 12226754
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [Abstract] [Full Text] [Related]

  • 9. [Epidermal growth factor-mediated NF-kappaB activation promotes uPA expression and invasiveness in pancreatic cancer cells].
    Zhang H, Liu XF, Li YJ, Zhou JP, Kong FM, Dong M.
    Zhonghua Zhong Liu Za Zhi; 2007 Dec 15; 29(12):909-12. PubMed ID: 18478929
    [Abstract] [Full Text] [Related]

  • 10. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 11. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
    Ha KH, Byun MS, Choi J, Jeong J, Lee KJ, Jue DM.
    Biochemistry; 2009 Aug 04; 48(30):7271-8. PubMed ID: 19591457
    [Abstract] [Full Text] [Related]

  • 12. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.
    Oncogene; 2007 Mar 01; 26(10):1385-97. PubMed ID: 16953224
    [Abstract] [Full Text] [Related]

  • 13. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
    Nielsen A, Scarlett CJ, Samra JS, Gill A, Li Y, Allen BJ, Smith RC.
    J Gastroenterol Hepatol; 2005 Feb 01; 20(2):256-63. PubMed ID: 15683429
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells.
    Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF.
    Cancer Res; 1992 May 01; 52(9):2489-96. PubMed ID: 1568219
    [Abstract] [Full Text] [Related]

  • 15. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 16. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, Koga K, Yamaguchi K, Tsuneyoshi M, Tanaka M, Katano M.
    Cancer Res; 2006 Jul 15; 66(14):7041-9. PubMed ID: 16849549
    [Abstract] [Full Text] [Related]

  • 17. Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells.
    Trevino JG, Gray MJ, Nawrocki ST, Summy JM, Lesslie DP, Evans DB, Sawyer TK, Shakespeare WC, Watowich SS, Chiao PJ, McConkey DJ, Gallick GE.
    Angiogenesis; 2006 Jul 15; 9(2):101-10. PubMed ID: 16871430
    [Abstract] [Full Text] [Related]

  • 18. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells.
    Cheng CY, Hsieh HL, Sun CC, Lin CC, Luo SF, Yang CM.
    J Cell Physiol; 2009 Apr 15; 219(1):183-93. PubMed ID: 19097143
    [Abstract] [Full Text] [Related]

  • 19. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Apr 15; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 20. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE.
    Oncogene; 2000 Nov 16; 19(48):5498-506. PubMed ID: 11114727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.